Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 27, 2025
EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
GlobeNewswire
·
March 27, 2025
WATERTOWN, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today …
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2024 and Business Highlights
GlobeNewswire
·
March 27, 2025
Enrollment complete for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease Anticipate topline results in late 2026 Topline results from the Phase 1 study investigating a subcutaneous sabirnetug …
BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
March 27, 2025
POMPANO BEACH, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces that …
Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates
GlobeNewswire
·
March 27, 2025
Revenue in 2024 increased 342% year-over-year to US$134.3 million (RMB980.7 million), attributable in part to Takeda’s option payment and strong sales growth of olverembatinib Sales of olverembatinib in China in 2024 increased 52% year-over-year to US$33.0 …
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update
GlobeNewswire
·
March 27, 2025
BETHESDA, Md., March 27, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
Laval Comiccon: A World of Fantasy in the North Shore
GlobeNewswire
·
March 27, 2025
LAVAL, Quebec, March 27, 2025 (GLOBE NEWSWIRE) -- After a long post-pandemic hiatus, fantasy fiction and pop culture fans will gather once again on April 26 and 27 for the 2nd edition of Laval Comiccon at L’Enclav de la Place Bell. The celebration of pop …
Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
GlobeNewswire
·
March 27, 2025
– Presented preclinical non-human primate (NHP) data at the 20th Congress of European Crohn’s and Colitis Organization in Inflammatory Bowel Diseases 2025 (ECCO) for SL-325, a potentially first-in-class blocking antibody to DR3, the receptor for TL1A; data …
Comiccon de Laval : La fiction fantastique et la culture populaire à leur meilleur sur la Rive-Nord
GlobeNewswire
·
March 27, 2025
LAVAL, Québec, 27 mars 2025 (GLOBE NEWSWIRE) -- Après une longue pause postpandémique, les amateurs de fiction fantastique et de culture populaire se retrouveront les 26 et 27 avril prochains à l’occasion de la 2e édition du Comiccon de Laval à l'Enclav de …
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2024
GlobeNewswire
·
March 27, 2025
Enrollment exceeds 60% of required number of patients in SERENITY At-Home pivotal Phase 3 safety trial evaluating 200 patients for acute treatment of agitation associated with bipolar disorders or schizophrenia Topline data expected in second half of 2025 …
Gyre Therapeutics Announces Publication of Protocol for Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis in Journal of Clinical and Translational Hepatology
GlobeNewswire
·
March 27, 2025
SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company with clinical development programs focusing on organ fibrosis, today announced the publication of the manuscript …
BeyondSpring Reports 2024 Year-End Financial Results and Highlights Key Clinical & Strategic Milestones
GlobeNewswire
·
March 27, 2025
Plinabulin Final Phase 3 Data Published in The Lancet Respiratory Medicine, Demonstrating Overall Survival Benefit in 2L/3L NSCLC EGFR Wild Type vs. Docetaxel Plinabulin Phase 2 Data Highlights Potential to Resensitize Tumors Progressed on PD-1/PD-L1 …
Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference
GlobeNewswire
·
March 27, 2025
WAYNE, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the preliminary results from its Ringer™ PBC IDE study were reported in a featured presentation at the …
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
GlobeNewswire
·
March 27, 2025
STAFFORD, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …
Arialief Nerve Health Supplement Review: Benefits, Side Effects & Where to Buy
GlobeNewswire
·
March 27, 2025
AURORA, Colo., March 27, 2025 (GLOBE NEWSWIRE) -- Nerve health has become a critical concern for many individuals suffering from conditions such as neuropathy, sciatica, and other forms of chronic nerve discomfort. While traditional pain relief methods …
LE QUÉBEC RATE UNE OCCASION DE GÉNÉRER DES REVENUS POUR LA SANTÉ PUBLIQUE
GlobeNewswire
·
March 27, 2025
MONTRÉAL, 27 mars 2025 (GLOBE NEWSWIRE) -- Avec déception, le Collectif Vital a constaté que le financement de la santé publique accuse un recul dans le budget 2025-2026 du ministre des Finances. La taxation des boissons sucrées aurait été un levier pour …
Alzheimer's Data Challenge Names Winners for Innovative Biomarker Research Competition
GlobeNewswire
·
March 27, 2025
Washington D.C., March 27, 2025 (GLOBE NEWSWIRE) -- International non-profit organization The Global Alzheimer’s Platform Foundation® (GAP) in collaboration with the Scottish Funding Council’s Brain Health Alliance for Research Challenges (ARC) and the …
Budget 2025-2026 : la santé publique amputée de 140 millions de dollars
GlobeNewswire
·
March 27, 2025
MONTRÉAL, 27 mars 2025 (GLOBE NEWSWIRE) -- L’Association pour la santé publique du Québec (ASPQ) exprime sa déception et son inquiétude après avoir consulté le budget 2025-2026 dévoilé par le ministre des Finances, M. Éric Girard. Non seulement le …
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
GlobeNewswire
·
March 27, 2025
REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Dr …
Pleco Therapeutics gibt positives Ergebnis des Pre-IND-Meetings mit der FDA für PTX-252 bei akuter myeloischer Leukämie bekannt
GlobeNewswire
·
March 27, 2025
NIJMEGEN, Niederlande, March 27, 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, ein im klinischen Stadium tätiges Biopharmazieunternehmen, das neuartige Therapien für schwer zu behandelnde Krebserkrankungen entwickelt, gibt ein positives Ergebnis seines Pre- …
Pleco Therapeutics annonce un résultat positif de sa réunion de pré-IND avec la FDA pour la poursuite du développement du PTX-252 dans le cadre du traitement de la leucémie myéloïde aiguë
GlobeNewswire
·
March 27, 2025
NIMÈGE, Pays-Bas, 27 mars 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, société biopharmaceutique de phase clinique qui développe des thérapies innovantes pour les cancers difficiles à traiter, annonce un résultat positif de sa réunion de pré-IND (Pre- …